Availability of new medicines in the US and Germany (2004 - 2018)

JAMA Network Open

30 August 2022 - In this cohort study comparing 599 medicine approvals in the US and Germany between 2004 and 2018, 92% of all new medicines approved in either country were available in the US, and 80% were available in Germany. 

The median approval time in Germany was extended by 4 months.

Read JAMA Network Open article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Market access , Germany